akusherstvoObstetrics, Gynecology and ReproductionАкушерство, Гинекология и Репродукция2313-73472500-3194IRBIS LLC10.17749/2313-7347.2017.12.2.039-047akusherstvo-493Research ArticleREVIEW ARTICLESНАУЧНЫЕ ОБЗОРЫCurrent approaches to alternative therapy in menopausal syndrome (a review)Современный взгляд на альтернативную терапию климактерического синдрома (литературный обзор)МамонтоваА. Г.MamontovaA. G.

Мамонтова Александра Георгиевна – врач акушер-гинеколог акушерского отделения патологии беременности № 1

454021, Челябинск, проспект Победы, 287

Mamontova Alexandra Georgievna – Obstetrician-gynecologist, Department of Obstetrics and Pathology of Pregnancy № 1

287, prospekt Pobedy, Chelyabinsk, 454021

УсольцеваЕ. Н.UsoltsevaЕ. N.

Усольцева Елена Николаевна – кандидат медицинских наук, ассистент кафедры акушерства и гинекологии Института дополнительного профессионального образования

454092, Челябинск, ул. Воровского, 64

Usoltseva Elena Nikolaevna – PhD, Assistant, Department of Obstetrics and Gynecology, Institute of Continuing Professional Education

64, ul. Vorovskogo, Chelyabinsk, 454092

elena-usoltseva@yandex.ruГБУЗ «Областная клиническая больница № 3»РоссияRegional Clinical Hospital № 3Russian FederationФГБОУ ВО «Южно-Уральский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияSouth Ural State Medical University, Health Ministry of Russian FederationRussian Federation2018260820181223947Copyright © Mamontova A.G., Usoltseva Е.N., 20182018Мамонтова А.Г., Усольцева Е.Н.Mamontova A.G., Usoltseva Е.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.gynecology.su/jour/article/view/493

Vasomotor symptoms are most common signs of the menopausal syndrome. Frequent episodes of flushes and hyperhidrosis affect sleep, mood, and quality of life. Menopausal hormone therapy (MHT) remains the «gold standard» of treatment. However, some women have contraindications to MHT, and others refuse to take hormones due to personal reasons. In such cases, alternative therapy may become an option. This article presents a review of the literature regarding the role of alternative therapy in the treatment of vasomotor symptoms. We searched Russian and international data bases for pharmacological products (natural and synthetic) used to relieve menopausal flushes. The review presents medication registered in the Russian Federation as well as products used abroad.

Вазомоторные симптомы – это наиболее часто встречающиеся проявления климактерического синдрома. Выраженные приливы и потливость оказывают влияние на сон, настроение, снижают качество жизни. «Золотым стандартом» лечения этих проявлений является менопаузальная гормональная терапия (МГТ). Однако у части женщин есть противопоказания к использованию МГТ, а некоторые отказываются от гормонального лечения по личным мотивам. В подобных случаях необходимы альтернативные методы лечения. В данной статье представлен обзор литературы по альтернативной терапии вазомоторных симптомов. Поиск проводился в отечественных и международных базах данных на русском и английском языках. Представлены фармакологические средства (растительного происхождения и синтетические), которые применяются для купирования приливов, в том числе препараты гормона эпифиза мелатонина. При этом в статью включены не только лекарственные средства, зарегистрированные на территории РФ, но и препараты, которые используются в других странах.

Менопаузаклимактерический синдромвазомоторные симптомыальтернативная терапияMenopausemenopausal syndromevasomotor symptomsalternative therapyReferencesKim M.Y., Choi S.D., Ryu A. Is complementary and alternative therapy effective for women in the climacteric period? J Menopausal Med. 2015; 21 (1): 28-35. DOI: 10.6118/jmm.2015.21.1.28.Kim M.Y., Choi S.D., Ryu A. Is complementary and alternative therapy effective for women in the climacteric period? J Menopausal Med. 2015; 21 (1): 28-35. DOI: 10.6118/jmm.2015.21.1.28.Менопаузальная гормонотерапия и сохранение здоровья женщин зрелого возраста. Клинические рекомендации (Протокол лечения). Письмо Министерства здравоохранения Российской Федерации от 02.10.2015 № 15-4/10/2-5804. URL: https://studfiles.net/preview/5778779/ [Дата доступа: 18.03.2018].Menopausal hormone therapy and maintaining the health of mature women. Clinical recommendations (Treatment protocol). [Menopauzal'naya gormonoterapiya i sohranenie zdorov'ya zhenshchin zrelogo vozrasta. Klinicheskie rekomendacii (Protokol lecheniya)]. Pis'mo Ministerstva zdravoohraneniya Rossijskoj Federacii ot 02.10.2015 № 15-4/10/2-5804 (in Russian). URL: https://studfiles.net/preview/5778779/ [Accessed: 18.03.2018].Eden J. Endocrine dilemma: Managing menopausal symptoms after breast cancer. Eur J Endocrinol. 2016; 174 (3): 71-7. DOI: 10.1530/EJE-15-0814. DOI: 10.1530/EJE-150814. PMID: 26466611.Eden J. Endocrine dilemma: Managing menopausal symptoms after breast cancer. Eur J Endocrinol. 2016; 174 (3): 71-7. DOI: 10.1530/EJE-15-0814. DOI: 10.1530/ EJE-15-0814. PMID: 26466611.Fisher W.I., Johnson A.K., Elkins G.R. et al. Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA Cancer J Clin. 2013; 63 (3): 167-92. DOI: 10.3322/caac.2117.Fisher W.I., Johnson A.K., Elkins G.R. et al. Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA Cancer J Clin. 2013; 63 (3): 167-92. DOI: 10.3322/caac.2117.Wiśniewska I., Jochymek B., Lenart-Lipińska M., Chabowski M. The pharmacological and hormonal therapy of hot flushes in breast cancer survivors. Breast Cancer. 2016; 23: 178-82. DOI: 10.1007/s12282-015-0655-2.Wiśniewska I., Jochymek B., Lenart-Lipińska M., Chabowski M. The pharmacological and hormonal therapy of hot flushes in breast cancer survivors. Breast Cancer. 2016; 23: 178-82. DOI: 10.1007/s12282-015-0655-2.Drewe J., Bucher K.A., Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. SpringerPlus. 2015; 4: 65. DOI: 10.1186/s40064-015-0808-y.eCollection 2015.Drewe J., Bucher K.A., Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. SpringerPlus. 2015; 4: 65. DOI: 10.1186/s40064-015-0808-y.eCollection 2015.Лапочкина Н.П., Маташева А.В., Крупенина Е.А. Селективные ингибиторы обратного захвата серотонина при климактерическом синдроме. Вестник Ивановской медицинской академии. 2015; 20 (4): 34-8.Lapochkina N.P., Matasheva A.V., Krupenina E.A. Selective serotonin reuptake inhibitors in menopausal syndrome. [Selektivnye ingibitory obratnogo zahvata serotonina pri klimaktericheskom syndrome]. Vestnik Ivanovskoj medicinskoj akademii. 2015; 20 (4): 34-8 (in Russian).Воронцова А.В., Звычайный М.А. Тканеселективный модулятор эстрогеновой активности адекватность «альтернативной» гормональной терапии. Уральский медицинский журнал. 2013; 4 (109): 16-21.Vorontsova A.V., Zvychayny M.A. The tissue selective modulator of estrogen activity is an adequate «alternative» hormone therapy. [Tkaneselektivnyj modulyator ehstrogenovoj aktivnosti adekvatnost' «al'ternativnoj» gormonal'noj terapii]. Ural'skij medicinskij zhurnal. 2013; 4 (109): 16-21 (in Russian).Goldberg T., Fidler B. Conjugated estrogens/ bazedoxifene (Duavee): a novel agent for the treatment of moderate-to-severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis. P T. 2015; 30 (3): 178-82. PMCID: PMC4357350.Goldberg T., Fidler B. Conjugated estrogens/ bazedoxifene (Duavee): a novel agent for the treatment of moderate-to-severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis. P T. 2015; 30 (3): 178-82. PMCID: PMC4357350.Pup L.D. Ospemifene: a safe treatment of vaginal atrophy. Eur Rev Med Pharmacol Sci Year. 2016; 20 (18): 3934-44.Pup L.D. Ospemifene: a safe treatment of vaginal atrophy. Eur Rev Med Pharmacol Sci Year. 2016; 20 (18): 3934-44.An K.C. Selective estrogen receptor modulators. Asian Spine J. 2016; 10 (4): 787-91. DOI: 10.4184/asj.2016.10.4.787.An K.C. Selective estrogen receptor modulators. Asian Spine J. 2016; 10 (4): 787-91. DOI: 10.4184/asj.2016.10.4.787.Pazhekattu R., Lau A.N., Adachi J.D. The tissue-selective estrogen complex: a review of current evidence. Rheumatol Ther. 2015; 2 (1): 47-58. DOI: 10.1007/s40744-015-0013-z.Pazhekattu R., Lau A.N., Adachi J.D. The tissue-selective estrogen complex: a review of current evidence. Rheumatol Ther. 2015; 2 (1): 47-58. DOI: 10.1007/s40744-015-0013-z.Gursoy A.Y., Kiseli M., Caglar G.S. Melatonin in aging women. Climacteric. 2015; 18: 1-7. DOI: 10.3109/13697137.2015.1052393.Gursoy A.Y., Kiseli M., Caglar G.S. Melatonin in aging women. Climacteric. 2015; 18: 1-7. DOI: 10.3109/13697137.2015.1052393.Parandavar N., Abdali K., Keshtgar S. et al. The effect of melatonin on climacteric symptoms in menopausal women; a double-blind, randomized controlled, clinical trial. Iran J Public Health. 2014; 43 (10): 1405-16.Parandavar N., Abdali K., Keshtgar S. et al. The effect of melatonin on climacteric symptoms in menopausal women; a double-blind, randomized controlled, clinical trial. Iran J Public Health. 2014; 43 (10): 1405-16.Kotlarczyk M.P., Lassila H.C., O'Neil C.K. et al. Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res. 2012; 52 (4): 414-26. DOI: 10.1111/j.1600-079X.2011.00956.x.Kotlarczyk M.P., Lassila H.C., O'Neil C.K. et al. Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res. 2012; 52 (4): 414-26. DOI: 10.1111/j.1600-079X.2011.00956.x.Chen W.Y., Giobbie-Hurder A., Gantman K. et al. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat. 2014; 145 (2): 381-8. DOI: 10.1007/s10549-014-2944-4.Chen W.Y., Giobbie-Hurder A., Gantman K. et al. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat. 2014; 145 (2): 381-8. DOI: 10.1007/s10549-014-2944-4.Мальцева Л.И., Гафарова Е.А., Гарипова Г.Х. Роль мелатонина в регуляции функции половых желез и возможности его применения в лечении симптомов патологического климакса. Успехи геронтологии. 2007; 20 (4): 68-74.Maltseva L.I., Gafarova E.A., Garipova G.Kh. The role of melatonin in regulation of gonads function and the possibility of its application in the treatment of symptoms of the pathological menopause. [Rol' melatonina v regulyacii funkcii polovyh zhelez i vozmozhnosti ego primeneniya v lechenii simptomov patologicheskogo klimaksa]. Uspekhi gerontologii. 2007; 20 (4): 68-74 (in Russian).Кузнецова И.В. Бурчаков Д.И. Возможности терапии климактерических симптомов с помощью препаратов мелатонина. Гинекология. 2015; 17 (5): 44-8.Kuznetsova I.V. Burchakov D.I. Possibilities for the treatment of climacteric symptoms with melatonin preparations. [Vozmozhnosti terapii klimaktericheskih simptomov s pomoshch'yu preparatov melatonina]. Ginekologiya. 2015; 17 (5): 44-8 (in Russian).Усольцева Е.Н., Брюхина Е.В. Применение мелатонина в лечении климактерического синдрома. II Международная научнопрактическая конференция Евразийского Научного Объединения «Современные концепции научных исследований»: сборник научных работ. М. 2015: 94.Usoltseva E.N., Bryukhina E.V. The use of melatonin in the treatment of climacteric syndrome. [Primenenie melatonina v lechenii klimaktericheskogo sindroma]. II Mezhdunarodnaya nauchno-prakticheskaya konferenciya Evrazijskogo Nauchnogo Ob"edineniya «Sovremennye koncepcii nauchnyh issledovanij»: sbornik nauchnyh rabot. Moskva. 2015: 94 (in Russian).Брюхина Е.В., Усольцева Е.Н. Мелатонин – ключ к адаптации женского организма при климактерическом синдроме. Врач. 2016; 4: 68-71.Bryukhina E.V., Usoltseva E.N. Melatonin is the key to the adaptation of the female body to climacteric syndrome. [Melatonin – klyuch k adaptacii zhenskogo organizma pri klimaktericheskom syndrome]. Vrach. 2016; 4: 68-71 (in Russian).Прилепская В.Н., Богатова И.К., Радзинский В.Е. Новое в профилактике и терапии климактерического синдрома. Гинекология. 2016; 148 (1): 7-12.Prilepskaya V.N., Bogatova I.K., Radzinsky V.E. New in the prevention and therapy of climacteric syndrome. [Novoe v profilaktike i terapii klimaktericheskogo sindroma]. Ginekologiya. 2016; 148 (1): 7-12 (in Russian).Овсянникова Т.В., Макаров И.О., Куликов И.А. Клиническая эффективность негормональных методов терапии у женщин в перименопаузе. Акушерство, гинекология и репродукция. 2013; 7 (3): 26-9.Ovsyannikova T.V., Makarov I.O., Kulikov I.A. Clinical efficacy of non-hormonal methods of therapy in women in perimenopause. [Klinicheskaya effektivnost' negormonal'nyh metodov terapii u zhenshchin v perimenopauze]. Akusherstvo, ginekologiya i reprodukciya. 2013; 7 (3): 26-9 (in Russian).Pandya K.J., Morrow G.R., Roscoe J.A. et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005; 366 (9488): 818-24.Pandya K.J., Morrow G.R., Roscoe J.A. et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005; 366 (9488): 818-24.Freedman R.R. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol. 2014; 142: 115-20. DOI: 10.1016/j.jsbmb.2013.08.010.Freedman R.R. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol. 2014; 142: 115-20. DOI: 10.1016/j.jsbmb.2013.08.010.Кузнецова И.В. Фитоэстрогены в лечении климактерических расстройств. Гинекология. 2012; 14 (6): 20-23. ISSN: 2079-5696.Kuznetsova I.V. Phytoestrogens in the treatment of climacteric disorders. [Fitoehstrogeny v lechenii klimaktericheskih rasstrojstv]. Ginekologiya. 2012; 14 (6): 20-23 (in Russian). ISSN: 2079-5696.Руководство по климактерию: руководство для врачей [Под ред. В.П. Сметник, В.И. Кулакова]. М.: МИА. 2001: 685 с. ISBN 5-89481-076-0.Manual on menopause: a guide for doctors. [Rukovodstvo po klimakteriyu: rukovodstvo dlya vrachej (Pod red. V.P. Smetnik, V.I. Kulakova)]. Moskva: MIA. 2001: 685 s (in Russian). ISBN 5-89481-076-0.Geller S.E., Studee L. Contemporary alternatives to plant estrogens for menopause. Maturitas. 2006; 55 (Suppl 1): 3-13.Geller S.E., Studee L. Contemporary alternatives to plant estrogens for menopause. Maturitas. 2006; 55 (Suppl 1): 3-13.Cheng G., Wilczek B., Warner M. et al. Isoflavone treatment for acute menopausal symptoms. Menopause. 2007; 14 (3 Pt 1): 468-73.Cheng G., Wilczek B., Warner M. et al. Isoflavone treatment for acute menopausal symptoms. Menopause. 2007; 14 (3 Pt 1): 468-73.D'Anna R., Cannata M.L., Atteritano M. et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause. 2007; 14 (4): 648-55.D'Anna R., Cannata M.L., Atteritano M. et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause. 2007; 14 (4): 648-55.Тихомиров А.Л. Изофлавоны сои в лечении климактерического синдрома. Гинекология. 2008; 10 (2): 44-6.Tikhomirov A.L. Soy isoflavones in the treatment of climacteric syndrome. [Izoflavony soi v lechenii klimaktericheskogo sindroma]. Ginekologiya. 2008; 10 (2): 44-6 (in Russian).Wuttke W., Seidlova-Wuttke D., Batzer I. Phytoestrogens: dangerous drugs or soft hormones? In: Menopause. The State of Art – in research and management. The Parthenon Publishing Group [Ed. H.P.G. Schntider]. Boca Raton, London, New York, Washington. 2003: 295-306.Wuttke W., Seidlova-Wuttke D., Batzer I. Phytoestrogens: dangerous drugs or soft hormones? In: Menopause. The State of Art – in research and management. The Parthenon Publishing Group [Ed. H.P.G. Schntider]. Boca Raton, London, New York, Washington. 2003: 295-306.Wuttke W., Jarry H., Seidlova-Wuttke D. Isoflavones – safe food additives or dangerous drugs? Ageing Res Rev. 2007; 6 (2): 150-88.Wuttke W., Jarry H., Seidlova-Wuttke D. Isoflavones – safe food additives or dangerous drugs? Ageing Res Rev. 2007; 6 (2): 150-88.Радзинский В.Е., Хамошина М.Б., Шестакова И.Г., Осьмакова А.А. Менопаузальный синдром – терапия и профилактика: доказанные возможности фитоэстрогенов. Доктор.Ру. 2015; 14 (115): 32-7.Radzinsky V.E., Khamoshina M.B., Shestakova I.G., Osmakova A.A. Menopausal syndrome – therapy and prevention: the proven possibilities of phytoestrogens. [Menopauzal'nyj sindrom – terapiya i profilaktika: dokazannye vozmozhnosti fitoehstrogenov]. Doktor.Ru. 2015; 14 (115): 32-7 (in Russian).Lethaby A., Marjoribanks J., Kronenberg F. et al. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013; 10 (12): CD001395. DOI: 10.1002/14651858.CD001395.pub4.Lethaby A., Marjoribanks J., Kronenberg F. et al. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013; 10 (12): CD001395. DOI: 10.1002/14651858.CD001395.pub4.Брюхина Е.В., Усольцева Е.Н., Иванова О.В. Качество жизни женщин в менопаузе: проблема, пути решения: монография. Челябинск: Изд-во ЮУГМУ. 2013: 99 c. ISBN 978-5-94507-184-1.Bryukhina E.V., Usoltseva E.N., Ivanova O.V. Life quality of women in menopause: the problem, the solutions: monograph. [Kachestvo zhizni zhenshchin v menopauze: problema, puti resheniya: monografiya]. Chelyabinsk: Izd-vo YuUGMU. 2013: 99 s (in Russian). ISBN 978-5-94507-184-1.Li L., Lv Y., Xu L., Zheng Q. Quantitative efficacy of soy isoflavones on menopausal hot flashes. Br J Clin Pharmacol. 2015; 79 (4): 593-604. DOI: 10.1111/bcp.12533.Li L., Lv Y., Xu L., Zheng Q. Quantitative efficacy of soy isoflavones on menopausal hot flashes. Br J Clin Pharmacol. 2015; 79 (4): 593-604. DOI: 10.1111/bcp.12533.Ho S.C., Chan A.S., Ho Y.P. et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause. 2007; 14 (3): 489-99.Ho S.C., Chan A.S., Ho Y.P. et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause. 2007; 14 (3): 489-99.Кузнецова И.В., Войченко Н.А., Акарачкова Е.А. Фитоэстрогены в лечении и профилактике менопаузальных расстройств. Медицинский совет. 2010; 3-4: 42-3.Kuznetsova I.V., Voichenko N.A., Akarachkova E.A. Phytoestrogens in the treatment and prevention of menopausal disorders. [Fitoehstrogeny v lechenii i profilaktike menopauzal'nyh rasstrojst. Medicinskij sovet. 2010; 3-4: 42-3 (in Russian).Udani J.K., Brown D.J., Tan M.O., Hardy M. Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a single-blinded, parallel, dose-comparison study. J Am Coll Nutr. 2013; 32 (6): 428-35. DOI: 10.1080/07315724.2013.849578.Udani J.K., Brown D.J., Tan M.O., Hardy M. Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a single-blinded, parallel, dose-comparison study. J Am Coll Nutr. 2013; 32 (6): 428-35. DOI: 10.1080/07315724.2013.849578.Pruthi S., Qin R., Terstreip S.A. et al. A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause. 2012; 19 (1): 48-53. DOI: 10.1097/gme.0b013e318223b021.Pruthi S., Qin R., Terstreip S.A. et al. A phase III, randomized, placebo-controlled, doubleblind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause. 2012; 19 (1): 48-53. DOI: 10.1097/gme.0b013e318223b021.Ghazanfarpour M., Sadegh R., Latifnejad R. at al. Effects of Flaxseed and Hypericum perforatum on hot flash, vaginal atrophy and estrogen-dependent cancers in menopausal women: a systematic review and metaanalysis. Avicenna J Phytomed. 2016; 6 (3): 273-83.Ghazanfarpour M., Sadegh R., Latifnejad R. at al. Effects of Flaxseed and Hypericum perforatum on hot flash, vaginal atrophy and estrogen-dependent cancers in menopausal women: a systematic review and metaanalysis. Avicenna J Phytomed. 2016; 6 (3): 273-83.Ghazanfarpour M., Sadeghi R., Abdolahian S., Latifnejad Roudsari S.A. The efficacy of Iranian herbal medicines in alleviating hot flashes: A systematic review. Int J Reprod Biomed (Yazd, Iran). 2016; 14 (3): 155-66.Ghazanfarpour M., Sadeghi R., Abdolahian S., Latifnejad Roudsari S.A. The efficacy of Iranian herbal medicines in alleviating hot flashes: A systematic review. Int J Reprod Biomed (Yazd, Iran). 2016; 14 (3): 155-66.Menopause. Biology and pathobiology. Eds. R.A. Lobo, J. Kelsey, R. Marcus. Academic Рress. 2000: 657 p.Menopause. Biology and pathobiology. Eds. R.A. Lobo, J. Kelsey, R. Marcus. Academic Рress. 2000: 657 p.Shahnazi M., Nahaee J., Mohammad-AlizadehCharandabi S., Bayatipayan S. Effect of black cohosh (cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trial. J Caring Sci. 2013; 2 (2): 105-13. DOI: 10.5681/jcs.2013.013.Shahnazi M., Nahaee J., Mohammad-AlizadehCharandabi S., Bayatipayan S. Effect of black cohosh (cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trial. J Caring Sci. 2013; 2 (2): 105-13. DOI: 10.5681/jcs.2013.013.Hajirahimkhan A., Dietz D.M., Bolton J.L. Botanical modulation of menopausal symptoms: Mechanisms of action? Planta Med. 2013; 79 (7): 538-53. DOI: 10.1055/s-0032-1328187.Hajirahimkhan A., Dietz D.M., Bolton J.L. Botanical modulation of menopausal symptoms: Mechanisms of action? Planta Med. 2013; 79 (7): 538-53. DOI: 10.1055/s-0032-1328187.Вихляева Е.М. Постменопаузальная терапия. Влияние на связанные с менопаузой симптомы, течение хронических заболеваний и качество жизни. М.: МЕДпресс-информ. 2008: 448 с. ISBN 5-98322-387-9.Vikhlyaeva E.M. Postmenopausal therapy. Effect on menopausal related symptoms, the course of chronic diseases and quality of life. [Postmenopauzal'naya terapiya. Vliyanie na svyazannye s menopauzoj simptomy, techenie hronicheskih zabolevanij i kachestvo zhizni]. Moskva: MEDpress-inform. 2008: 448 s (in Russian). ISBN 5-98322-387-9.Рафаэлян И.В., Балан В.Е., Ковалева Л.А. Эффективность и безопасность применения экстракта цимицифуги рацемозы в терапии климактерического синдрома в течение года (результаты собственного исследования). Медицинский совет. 2014; 7: 54-7.Rafaelian I.V., Balan V.E., Kovaleva L.A. Efficacy and safety of the application of richemose cymicifuge extract in the treatment of climacteric syndrome during the year (results of own research. [Effektivnost' i bezopasnost' primeneniya ekstrakta cimicifugi racemozy v terapii klimaktericheskogo sindroma v techenie goda (rezul'taty sobstvennogo issledovaniya)]. Medicinskij sovet. 2014; 7: 54-7 (in Russian).Apaydin E.A., Maher A.R., Shanman R. at al. A systematic review of St. John’s wort for major depressive disorder. Syst Rev. 2016; 5 (1): 148. DOI: 10.1186/s13643-016-0325-2.Apaydin E.A., Maher A.R., Shanman R. et al. A systematic review of St. John’s wort for major depressive disorder. Syst Rev. 2016; 5 (1): 148. DOI: 10.1186/s13643-016-0325-2.Lee H.W., Choi J., Lee Y. at al. Ginseng for managing menopausal woman's health A systematic review of doubleblind, randomized, placebo-controlled trials. Medicine (Baltimore). 2016; 95 (38): e4914. DOI: 10.1097/md.0000000000004914.Lee H.W., Choi J., Lee Y. et al. Ginseng for managing menopausal woman's health A systematic review of double-blind, randomized, placebo-controlled trials. Medicine (Baltimore). 2016; 95 (38): e4914. DOI: 10.1097/md.0000000000004914.Mirabi P., Mojab F. The effects of valerian root on hot flashes in menopausal women. Iran J Pharm Res. 2013; 12 (1): 217-22.Mirabi P., Mojab F. The effects of valerian root on hot flashes in menopausal women. Iran J Pharm Res. 2013; 12 (1): 217-22.Зильбер В.С. Место гомеопатии в системе Российского здравоохранения. Часть I. Клиническая медицина. 2014; 92 (3): 74-8.Zilber V.S. Place of homeopathy in the system of Russian public health. Part I. [Mesto gomeopatii v sisteme Rossijskogo zdravoohraneniya. Chast' I]. Klinicheskaya medicina. 2014; 92 (3): 74-8 (in Russian).

The authors declare that there are no conflicts of interest present.